Cargando…
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
BACKGROUND: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has a wide range of effects on glucose metabolism and cardiovascular function (e.g., improving insulin sensitivity, reduction in appetite, modulation of heart rate, blood pressure and myocardial contractility). Metabolic syndrom...
Autores principales: | Yamaoka-Tojo, Minako, Tojo, Taiki, Takahira, Naonobu, Matsunaga, Atsuhiko, Aoyama, Naoyoshi, Masuda, Takashi, Izumi, Tohru |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891690/ https://www.ncbi.nlm.nih.gov/pubmed/20470376 http://dx.doi.org/10.1186/1475-2840-9-17 |
Ejemplares similares
-
Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome
por: Yamaoka-Tojo, Minako, et al.
Publicado: (2011) -
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
por: Yamaoka-Tojo, Minako, et al.
Publicado: (2009) -
Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis
por: Namba, Sayaka, et al.
Publicado: (2015) -
Molecular Mechanisms Underlying the Progression of Aortic Valve Stenosis: Bioinformatic Analysis of Signal Pathways and Hub Genes
por: Tojo, Taiki, et al.
Publicado: (2023) -
Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
por: Kanasaki, Keizo, et al.
Publicado: (2019)